SWOT Analysis

What is SWOT Analysis

SMS Pharmaceuticals Ltd.

Strengths 21 S

Weakness 6 W

Opportunity 6 O

Threats 2 T

What is SWOT Analysis ?

Strengths, Weaknesses, Opportunities and Threats Analysis is a real time check on stock health throughout the day. SWOT looks at financials, management quality, technical parameters and valuations to identify positives and negatives for every stock.

These are then classified as strengths, weaknesses, opportunities that investors can leverage, and threats that might impact company health.

• Strengths
• Weakness
• Opportunity
• Threats

• Companies with 10% increase in share price over three months, with rising net profit growth
• Strong Momentum: Price above short, medium and long term moving averages
• Upcoming results for Nifty500 companies with previous quarter net profit growth greater than 10% YoY and QoQ
• Consistent Highest Return Stocks over Five Years
• Mid-range Performer (DVM)
• Relative Outperformance versus Industry over 1 Month
• Rising Net Cash Flow and Cash from Operating activity
• Companies with high TTM EPS Growth
• Annual Profit Growth higher than Sector Profit Growth
• PEG lower than Industry PEG
• Stocks gaining versus previous close, open price and RSI
• Relative Outperformance versus Industry over 1 Week
• Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
• Relative Outperformance versus Industry over 1 Month
• Companies with rising net profit margins - quarterly as well as TTM basis
• Growth in Net Profit with increasing Profit Margin (QoQ)
• Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
• RSI indicating price strength
• Top Gainers
• Volume Shockers
• Stocks Outperforming their Industry Price Change in the Quarter

• Promoters increased pledged shares QoQ
• Stocks with Expensive Valuations according to the Trendlyne Valuation Score
• Increasing Trend in Non-Core Income
• High promoter stock pledges
• Highest increase in pledges by promoters
• Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

• Companies with Upcoming Results
• Mutual Funds Increased Shareholding in Past Month
• Big Deal (Insider and SAST) buys last month greater than 1% of total shares
• Big Deal (Insider and SAST) buys last week greater than 1% of total shares
• Mutual Funds Increased Shareholding over the Past Two Months
• Mf buying for 2 months

• MFs decreased their shareholding last quarter
• US FDA Warning Letter